1. 2022
  2. Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates

    Reiss, E. I. M. M., van Haaren, M. M., van Schooten, J., Claireaux, M. A. F., Maisonnasse, P., Antanasijevic, A., Allen, J. D., Bontjer, I., Torres, J. L., Lee, W-H., Ozorowski, G., Vázquez Bernat, N., Kaduk, M., Aldon, Y., Burger, J. A., Chawla, H., Aartse, A., Tolazzi, M., Gao, H., Mundsperger, P., & 10 othersCrispin, M., Montefiori, D. C., Karlsson Hedestam, G. B., Scarlatti, G., Ward, A. B., Le Grand, R., Shattock, R., Dereuddre-Bosquet, N., Sanders, R. W. & van Gils, M. J., Dec 2022, In: npj Vaccines. 7, 1, p. 152 152.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies

    Aartse, A., Mortier, D., Mooij, P., Hofman, S., van Haaren, M. M., Corcoran, M., Karlsson Hedestam, G. B., Eggink, D., Claireaux, M., Bogers, W. M. J. M., van Gils, M. J. & Koopman, G., 3 Nov 2022, In: Frontiers in immunology. 13, 1026951.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic

    Grobben, M., Juncker, H. G., van der Straten, K., Lavell, A. H. A., Schinkel, M., Buis, D. T. P., Wilbrink, M. F., Tejjani, K., Claireaux, M. A. F., Aartse, A., de Groot, C. J. M., Pajkrt, D., Bomers, M. K., Sikkens, J. J., van Gils, M. J., van Goudoever, J. B. & van Keulen, B. J., 31 Aug 2022, In: Microbiology spectrum. 10, 4, p. e0040522

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2021
  6. Influenza a virus hemagglutinin trimer, head and stem proteins identify and quantify different hemagglutinin-specific b cell subsets in humans

    Aartse, A., Eggink, D., Claireaux, M., van Leeuwen, S., Mooij, P., Bogers, W. M., Sanders, R. W., Koopman, G. & van Gils, M. J., 1 Jul 2021, In: Vaccines. 9, 7, 717.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2020
  8. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

    Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., Bentlage, A. E. H., van Haaren, M. M., Guerra, D., Burger, J. A., Schermer, E. E., Verheul, K. D., van der Velde, N., van der Kooi, A., van Schooten, J., van Breemen, M. J., & 13 othersBijl, T. P. L., Sliepen, K., Aartse, A., Derking, R., Bontjer, I., Kootstra, N. A., Joost Wiersinga, W., Vidarsson, G., Haagmans, B. L., Ward, A. B., de Bree, G. J., Sanders, R. W. & van Gils, M. J., 7 Aug 2020, In: Science. 369, 6504, p. 643-650 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains

    de Jong, N. M. C., Aartse, A., van Gils, M. J. & Eggink, D., 2 Jun 2020, In: Expert review of vaccines. 19, 6, p. 563-577 15 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

ID: 4395696